
Welcome
Admissions
Curriculum
Seminar Program
Research
Faculty
Staff & PostDocs
Students
Alumni & Friends
Medicinal Chemistry HOME
|

|
Alan W. Curnow
Research Scientist
Procter & Gamble Pharmaceuticals
Discovery Research - Anti-infective Focus Area- Biology Section
Email: curnow.aw@pg.com
Education
Postdoctoral Research Fellow, Yale University, New Haven, Connecticut (1998)
Ph.D. in Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan (1995)
(Ph.D. studies supported in part by the Pharmacological Sciences Training Program (NIH-GM07767))
Pharm.D., University of Michigan, Ann Arbor, Michigan (1990)
Research
I have recently joined Procter & Gamble Pharmaceuticals where we use a target-based approach in an effort to discover novel antibacterial compounds. As a member of a project team, I collaborate with several other scientists in Discovery Research including: High Throughput Screening Technologists to identify inhibitors of a specific enzyme essential for bacterial cell viability, Structural Biologists for computational chemistry and enzyme structure modeling to elucidate how such inhibitors interact with the enzyme and Anti-Infective Medicinal Chemists to re-synthesize and expand around inhibitor hits and inhibitor design. The ultimate goal of this collaboration is aimed at understanding the mechanism of action of specific enzyme inhibitors in whole bacterial cells and correlating this with antibacterial activity. In the future, we will broaden the number of proteins being pursued to encompass other novel or underexploited antimicrobial targets.
Prior to joining P&GP, I spent 3 years in the laboratory of Professor Dieter Söll at Yale University in a postdoctoral research position. At Yale, I was involved in several projects all related to the process of aminoacyl-tRNA formation. The types of approaches that I used included genomics/bioinformatics and molecular biology as well as techniques in protein chemistry and enzymology. The following summarizes that work: Cognate aminoacyl-tRNA synthesis is instrumental to the core protein translation machinery and, as such, is essential for cell viability. The full complement of aminoacyl-tRNAs necessary for translation is not entirely formed by the aminoacyl-tRNA synthetases. In a significant number of cases, the aminoacyl-tRNA synthetases serve to activate a non-cognate amino acid, while the generation of the correct aminoacyl-tRNA is subsequently brought about by a second protein. The use of such pathways is well documented. However, we have now found that in several archaea an additional aminoacyl-tRNA, Asn-tRNA, is also formed by transformation of a mischarged tRNA rather than by direct aminoacylation with asparaginyl-tRNA synthetase (Curnow et al., 1996). Biochemical evidence indicates that aspartyl-tRNA synthetase initially synthesizes Asp-tRNA, which is subsequently converted to Asn-tRNA in a distinct tRNA-dependent transamidation reaction (Curnow et al., 1998). This is analogous to the indirect pathway for Gln-tRNA formation (Curnow et al., 1997). We have also shown that several members of the Archaea contain a functional LysRS with no resemblance to known bacterial or eukaryal LysRSs (Ibba et al., 1997). While it was initially assumed that this novel type of LysRS was confined to certain Archaea, continued genomic sequencing efforts have suggested that it may also be found in some bacteria. This was confirmed by the cloning of a gene encoding a functional archaeal-type LysRS from the Lyme Disease Spirochete Borrelia burgdorferi. The spirochetes are a phylogenetically ancient bacterial group and the apparent existence of archaeal-type genes in these organisms raises a number of issues concerning their evolutionary origin and development (Ibba et al., 1999)., as well as providing a novel class of potential drug targets.
Publications
- Li, T., Graham, D.E., Stathopoulos, C., Haney, P.J., Kim, H.S., Vothknecht, U.C., Kitabatake, M., Hong, K.W., Eggertsson, G., Curnow, A.W., Lin, W., Celic, I., Whitman, W. and Söll, D.(1999) Cysteinyl-tRNA formation: the last puzzle of aminoacyl-tRNA synthesis. FEBS Lett. 462 (3), 302-6.
- Ibba, M., Curnow, A.W., Bono, J.L., Rosa, P.A., Woese, C.R. and Söll, D.(1999) Archaeal aminoacyl-tRNA Synthesis: Unique Determinants of a Universal Genetic Code? Biol. Bull. 196, 335-7.
- Curnow, A.W., Tumbula, D., Pelaschier, J., Min, B. and Söll, D. (1998) Glutamyl-tRNAGln amidotransferase in Deinococcus radiodurans may be restricted to asparagine biosynthesis. Proc. Natl. Acad. Sci. USA 95, 12838-43.
- Curnow, A.W., Hong, K.W., Yuan, R.S., Kim, S.I., Winkler, W., Martins, O., Henkin T. and Söll, D. (1997) Isolation and Purification of Recombinant Glu-tRNAGln amidotransferase: A novel and essential translation component, Proc. Nat. Acad. Sci. USA 94, 11819-26.
- Ibba M., Morgan, S., Curnow, A.W., Pridmore, D.R., Vothknecht, U.C., Lin, W., Woese, C.R. and Söll, D. (1997) Euryarchaeal Lys-tRNA synthetase: Resemblance to class I synthetases, Science 78, 1119-22.
- Curnow, A.W., Hong, K.W., Yuan, R.S. and Söll, D. (1997) tRNA-dependent amino acid transformations. Nucleic Acids Symp. Ser. 36, 2-4.
- Ibba, M., Celic, I., Curnow, A.W., Kim, H.S., Pelaschier, J., Tumbula, D., Vothknecht, U.C., Woese, C.R. and Söll, D. (1997) Aminoacyl-tRNA synthesis in Archaea. J Nucleic Acids Symp. Ser. 37, 305-6.
- Ibba, M., Curnow, A.W. and Söll, D. (1997) Aminoacyl-tRNA synthesis: divergent routes to a common goal. Trends Biochem. Sci. 22, 39-42.
- Curnow, A.W., Ibba, M. and Söll, D. (1996) tRNA-dependent asparagine formation. Nature (London) 382, 589-90.
- Curnow, A.W. and Garcia, G.A. (1995) tRNA-guanine transglycosylase from E. coli. Minimal tRNA structure and sequence requirements for recognition. J. Biol. Chem. 270, 17264-7.
- Chong, S., Curnow, A.W., Huston, T.J. and Garcia, G.A. (1995) tRNA-guanine transglycosylase from Escherichia coli is a zinc-metalloprotein. Site-directed mutagenesis studies to identify the zinc ligands.
Biochemistry 34, 3694-701.
- Curnow, A.W. and Garcia, G.A. (1994) tRNA-guanine transglycosylase from Escherichia coli: recognition of dimeric, unmodified tRNATyr. Biochimie 12, 1183 91.
- Curnow, A.W., Garcia, G.A., Kung, F.L. and Koch, K. (1993) tRNA-guanine transglycosylase from E. coli: gross tRNA structural requirements for recognition. Biochemistry 32, 5239-46.
Questions/Comments
Rackham School of Graduate Studies | College of Pharmacy
page last modified: Wednesday, 03-May-2000 15:45:51 EDT
©2001 University of Michigan
|